Oraya Therapeutics
ID: 5290559Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.
3
Funding Rounds
$64.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** Ge***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Oraya Therapeutics has raised a total of $64m in funding over 3 rounds.
Key Insights:
- Oraya Therapeutics Series C round: $42m
- Oraya Therapeutics Series B round: $18m
- Oraya Therapeutics Series A round: $4m
Industries
Oraya Therapeutics is active in the following industries: